Breast cancer-specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast

American Journal of Surgery

Volumn 192, Issue 4, 2006, Pages 416-419

  Lee, Laura A ^a   Silverstein, Melvin J ^a   Chung, Cathie T ^a   Macdonald, Heather ^a   Sanghavi, Premal ^a   Epstein, Melinda ^a   Holmes, Dennis R ^a   Silberman, Howard ^a   Ye, Wei ^a   Lagios, Michael D ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Breast Cancer Consultation Service   (United States)

Author keywords

Breast cancer mortality; DCIS; Ductal carcinoma in situ; Local recurrence

Indexed keywords

ARTICLE; BREAST CANCER; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER THERAPY; CARCINOMA IN SITU; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; PROBABILITY;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33748428310     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2006.06.005     Document Type: Article

References (18)

1. Morrow M. Surgical overview in the treatment of ductal carcinoma in situ. In: Silverstein M.J. (Ed). Ductal Carcinoma In Situ of the Breast. 2nd ed. (2002), Williams & Wilkins, Baltimore, MD 275-286
2. Silverstein M.J., Barth A., Poller D.N., et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 31 (1995) 1425-1427
3. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 (2002) 1227-1232
4. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
5. Fisher B., Costantino J., Redmond C., et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 328 (1993) 1581-1586
6. Houghton J., George W.D., Cuzick J., et al. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial. Lancet 362 (2003) 95-102
7. Julien J.P., Bijker N., Fentiman I.S., et al., EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomized phase III trail 10853. Lancet 355 (2000) 528-533
8. Bijker N., Peterse J.L., Duchateau L., et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 19 (2001) 2263-2271
9. Fisher B., Land S., Mamounas E., et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 28 (2001) 400-418
10. Fisher E.R., Costantino J., Fisher B., et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). Cancer 75 (1995) 1310-1319
11. Mamounas E., Fisher B., Dingam J., et al. Effects of breast irradiation following lumpectomy in intraductal carcinoma (DCIS): update results from NSABP B-17. Proc Soc Surg Oncol 50 (1997) 7
12. Fisher E.R., Dignam J., Tan-Chiu E., et al. Pathologic finding from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 86 (1999) 429-438
13. Fisher B., Dignam J., Wolmark N., et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16 (1998) 441-452
14. Julien J.P., Bijker N., Fentiman I.S., et al. Radiotherapy in breast conserving treatment for ductal carcinoma in situ: first results of the EORTC randomized phase III trial 10853. Lancet 355 (2000) 528-533
15. Fisher B., Anderson S., Fisher E., et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 338 (1991) 327-331
16. Solin L.J., Kurtz J., Fourquet A., et al. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 14 (1996) 754-763
17. Rosen P.P., Groshen S., Saigo P.E., et al. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol 7 (1989) 355-366
18. Rosen P.P., Groshen S., Kinne D.W., et al. Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up. J Clin Oncol 11 (1993) 2090-2100